Alirocumab and Cardiovascular Outcomes after Acute Coronary SyndromeGregory G. Schwartz, Andreas M. Zeiher, Jay M. Edelberg et al.|New England Journal of Medicine|2018Cited by 3.5k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trialAdrian F. Hernandez, Lauren B. Cooper, Jennifer B. Green et al.|The Lancet|2018Cited by 1.8k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary SyndromesPierluigi Tricoci, Kenneth W. Mahaffey, Zhen Huang et al.|New England Journal of Medicine|2011Cited by 753